← Back to Search

amnion-chorion membrane for Gum Disease

N/A
Recruiting
Research Sponsored by Harvard Medical School
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This trial will compare the healing of the palatal donor site when an allograft membrane is used versus when no allograft membrane is used.

Eligible Conditions
  • Gum Disease
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postoperative pain as evaluated by subjects using the Visual Analogue Scale
Secondary outcome measures
Pain Catastrophizing Scale (PCS)
Pain management (medication usage)
Patient satisfaction as evaluated by Visual Analogue Scale
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Allograft and SuturesExperimental Treatment1 Intervention
Patients assigned to Allograft and Sutures will have allograft placed and secured with sutures on the donor site.
Group II: SuturesActive Control1 Intervention
Patients assigned to Sutures group will not have the allograft placed on the donor site. One current clinical standard of practice is to place sutures on donor site. Patients assigned to Sutures group will have sutures placed on donor site.

Find a Location

Who is running the clinical trial?

Harvard Medical SchoolLead Sponsor
29 Previous Clinical Trials
40,649 Total Patients Enrolled
Harvard Medical School (HMS and HSDM)Lead Sponsor
195 Previous Clinical Trials
1,315,848 Total Patients Enrolled
~2 spots leftby Jun 2025